Literature DB >> 19358835

Assessment of matrix metalloproteinase (MMP)-2, MMP-8, MMP-9, and their inhibitors, the tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in obese children and adolescents.

Vanessa A Belo1, Debora C Souza-Costa, Carla M Lana, Fabio L D Caputo, Andrea M Marcaccini, Raquel F Gerlach, Marcus G Bastos, Jose E Tanus-Santos.   

Abstract

OBJECTIVES: To compare the circulating levels of matrix metalloproteinase (MMP)-8, pro-MMP-2, pro-MMP-9, and total MMP-9, their endogenous inhibitors, the tissue inhibitors of metalloproteinases (TIMP)-1 and TIMP-2, and the MMP-8/TIMP-1, MMP-9/TIMP-1, and MMP-2/TIMP-2 ratios in normotensive obese children and adolescents with those found in non obese children and adolescents. DESIGN AND METHODS: We studied 40 obese and 40 non obese (controls) children and adolescents in this cross-sectional study. MMP and TIMP concentrations were measured in plasma samples by gelatin zymography and ELISA.
RESULTS: Obese children and adolescents had higher circulating MMP-8 concentrations, lower plasma TIMP-1 concentrations, and higher MMP-8/TIMP-1 ratios than non obese controls (P<0.05). We found no differences in pro-MMP-9 or total MMP-9 levels, or in MMP-9/TIMP-1 ratios between groups (P>0.05). While we found no significant differences in pro-MMP-2 levels (P>0.05) obese subjects had higher TIMP-2 concentrations and lower pro-MMP-2/TIMP-2 ratios (P<0.05) than non obese controls.
CONCLUSIONS: In conclusion, we found evidence indicating higher net MMP-8 (but not MMP-9 and MMP-2) activity in childhood obesity. The increased MMP-8 levels found in obese children suggest a possibly relevant pathophysiological mechanism that may be involved in the increase of cardiovascular risk associated with childhood obesity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19358835     DOI: 10.1016/j.clinbiochem.2009.03.025

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  18 in total

1.  Endogenous nitric oxide formation correlates negatively with circulating matrix metalloproteinase (MMP)-2 and MMP-9 levels in black subjects.

Authors:  Ingrid F Metzger; Valéria C Sandrim; Jose E Tanus-Santos
Journal:  Mol Cell Biochem       Date:  2011-09-29       Impact factor: 3.396

2.  Plasma levels of matrix metalloproteinase-8 in patients with carotid atherosclerosis.

Authors:  Tamara Djurić; Maja Zivković; Aleksandra Stanković; Ana Kolaković; Djole Jekić; Vesna Selaković; Dragan Alavantić
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

3.  Effects of statins on matrix metalloproteinases and their endogenous inhibitors in human endothelial cells.

Authors:  Tatiane C Izidoro-Toledo; Danielle A Guimaraes; Vanessa A Belo; Raquel F Gerlach; Jose Eduardo Tanus-Santos
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-03-30       Impact factor: 3.000

4.  Imbalanced circulating matrix metalloproteinases in polycystic ovary syndrome.

Authors:  Valéria A Gomes; Carolina S Vieira; Anna L Jacob-Ferreira; Vanessa A Belo; Gustavo M Soares; Janaína B F Fernandes; Rui A Ferriani; Jose E Tanus-Santos
Journal:  Mol Cell Biochem       Date:  2011-03-25       Impact factor: 3.396

5.  Nitric oxide attenuates matrix metalloproteinase-9 production by endothelial cells independent of cGMP- or NFκB-mediated mechanisms.

Authors:  Cesar A Meschiari; Tatiane Izidoro-Toledo; Raquel F Gerlach; Jose E Tanus-Santos
Journal:  Mol Cell Biochem       Date:  2013-03-03       Impact factor: 3.396

Review 6.  Fat fibrosis: friend or foe?

Authors:  Ritwik Datta; Michael J Podolsky; Kamran Atabai
Journal:  JCI Insight       Date:  2018-10-04

7.  Effect of metabolic syndrome risk factors and MMP-2 genetic variations on circulating MMP-2 levels in childhood obesity.

Authors:  Vanessa A Belo; Marcelo R Luizon; Patrícia C Carneiro; Valéria A Gomes; Riccardo Lacchini; Carla M M Lanna; Debora C Souza-Costa; Jose E Tanus-Santos
Journal:  Mol Biol Rep       Date:  2012-12-16       Impact factor: 2.316

8.  The effects of NAMPT haplotypes and metabolic risk factors on circulating visfatin/NAMPT levels in childhood obesity.

Authors:  V A Belo; M R Luizon; R Lacchini; J A Miranda; C M M Lanna; D C Souza-Costa; J E Tanus-Santos
Journal:  Int J Obes (Lond)       Date:  2013-09-12       Impact factor: 5.095

9.  Doxycycline reduces osteopenia in female rats.

Authors:  Fellipe A T de Figueiredo; Roberta C Shimano; Edilson Ervolino; Dimitrius L Pitol; Raquel F Gerlach; Joao Paulo M Issa
Journal:  Sci Rep       Date:  2019-10-25       Impact factor: 4.379

10.  EPS-LASSO: test for high-dimensional regression under extreme phenotype sampling of continuous traits.

Authors:  Chao Xu; Jian Fang; Hui Shen; Yu-Ping Wang; Hong-Wen Deng
Journal:  Bioinformatics       Date:  2018-06-15       Impact factor: 6.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.